tiprankstipranks
Yunkang Group Limited (HK:2325)
HKEX:2325
Hong Kong Market

Yunkang Group Limited (2325) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2325 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Yunkang
Group Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2325 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:2325 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

2325 Financial Forecast

No data currently available

2325 Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

2325 Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Analyst Performance
Any
Any
Analyst Rating
Any
Any
Upside / Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CMB International Securities
HK$13.78
Buy
HK$13.78
(53.45% Upside)
Reiterated
04/09/24
We estimated that the proportion of revenue generated from COVID business has declined from approximately 80% in 2022 to approximately 1% in 2023. Therefore, we think the revenue will resume normal growth in 2024E driven by the solid performance of its core business such as pathology diagnosis, infectious diseases testing, genetic diseases diagnosis and routine testing, etc.  Diagnostic testing services for medical institution alliances became the largest business segment. Group has established 416 jointly constructed on-site diagnostic centers (vs. 398 at end-2022), serving over 1,500 medical institutions.

Best Analysts Covering Yunkang Group Limited

Which Analyst Should I Follow If I Want to Buy HK:2325 and Sell After:
1 Month
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-1.60%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -1.60% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-9.40%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -9.40% per trade.
1 Year
Jill WuCMB International Securities
Success Rate
0/2 ratings generated profit
0%
Average Return
-23.30%
reiterated a buy rating 3 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -23.30% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-23.30%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -23.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2325 Analyst Recommendation Trends

Rating
Sep 23
Apr 24
Strong Buy
0
0
Buy
1
2
Hold
0
0
Sell
0
0
Strong Sell
0
0
total
1
2
In the current month, 2325 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2325 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

2325 Stock Forecast FAQ

What is HK:2325’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:2325’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:2325, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Yunkang Group Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Yunkang Group Limited’s share price target?
      Currently, no data Available
      What do analysts say about Yunkang Group Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Yunkang Group Limited?
      To buy shares of HK:2325, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis